Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(17%)
Results Posted
50%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_1
1
17%
Ph phase_2
1
17%
Ph phase_4
1
17%
Ph not_applicable
3
50%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Not yet recruiting1
Recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 41 (16.7%)
N/A3 (50.0%)

Trials by Status

not_yet_recruiting117%
completed233%
recruiting117%
terminated117%
unknown117%

Recent Activity

1 active trials
Showing 5 of 6
not_yet_recruitingnot_applicable

Evaluating the LGG of on Acute Infectious Diarrhea in Children

NCT07342101
recruitingphase_4

The Effects of Probiotics, Lactobacillus GG, in the Treatment of Abdominal Pain in Children With Functional Abdominal Pain Disorders

NCT06310733
terminatedphase_1

Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer

NCT01790035
completedphase_2

Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis

NCT01773967
completednot_applicable

Defining the Normal Human Response to Probiotics

NCT03140878
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07342101Not Applicable

Evaluating the LGG of on Acute Infectious Diarrhea in Children

Not Yet Recruiting
NCT06310733Phase 4

The Effects of Probiotics, Lactobacillus GG, in the Treatment of Abdominal Pain in Children With Functional Abdominal Pain Disorders

Recruiting
NCT01790035Phase 1

Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer

Terminated
NCT01773967Phase 2

Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis

Completed
NCT03140878Not Applicable

Defining the Normal Human Response to Probiotics

Completed
NCT01454661Not Applicable

Probiotics and Early Microbial Contact in Preterm Neonates

Unknown

All 6 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
6